Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Development
Pharmaceuticals company names protein structure service provider
August 6th, 2004
Sirenade Pharmaceuticals AG announced today that it has been selected by Solvay Pharmaceuticals as a provider for structural biology services. Under the agreement Sirenade will perform structural biology services related to an undisclosed target protein provided by Solvay. The work to be performed will range from cloning and expression of Solvay's target protein to the characterization of its structure. Sirenade will also provide Solvay with co-crystal structures of the target protein in complex with Solvay's compounds. Sirenade will receive service payments and additional payments are possible upon reaching certain milestones. Sirenade has used its...
Source: Genomics & Genetics Weekly (2004-08-06)
|
